Efficacy and safety of ipilimumab in metastatic melanoma...

Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)

McDermott, D., Haanen, J., Chen, T.- T., Lorigan, P., O'Day, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt291
Date:
October, 2013
File:
PDF, 90 KB
english, 2013
Conversion to is in progress
Conversion to is failed